PharmaSynth has been authorised as GMP manufacturer of Active Pharmaceutical Ingredients (API's)
In autumn 2018 PharmaSynth's manufacturing site was audited by the State Agency of Medicines, the competent authority of Estonia.
The GMP certificate can be viewed on the homepage of the European Inspections database EudraGMDP site: API registration number 726 (AS-mf) and GMP certificate number IN-2-14/19/1 (API), country Estonia.
For further information regarding API’s production please contact Jukka Hiltunen at firstname.lastname@example.org, chief chemist, Olavi Loog at email@example.com or our chief scientific officer, Hans Christiaans at firstname.lastname@example.org.
Product related updates
The GMP certified precursor for [18F]SynVesT-1/[18F]SDM-8/[18F]MNI-1126 (an [18F]-analog of UCB-J) and the reference standard for SDM-8 / MNI-1126 are available.
[18F]UCB-J. Now also the trimethylstannyl precursor for the exact 18F analog of UCB-J is available.
by Johanna Rokka , Eva Schlein and Jonas Eriksson from Uppsala has been published. https://doi.org/10.1186/s41181-019-0080-5
BU99007, Precursor for I2BS tracer [11C]BU99008
N-Desmethyl-AZ10419369, Precursor for 5-HT1B receptor ligand [11C]AZ10419369
Upcoming events where you can meet us
No upcoming events
Past events where we have been